Forecast & Rating6 analysts currently cover Lakefront Biotherapeutics, with about 16.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $23.61, about 17.1% downside from the current price of $28.49. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most institutions are cautious on Lakefront Biotherapeutics's outlook. Data as of Aug 22, 2026; for reference only and not investment advice.
Aug 20, 2026Price forecast
$23.61-17.13%
Forecast & RatingHold
6analysts
- Strong buy16.67%
- Buy0.00%
- Hold66.67%
- Sell16.67%
- Strong sell0.00%
Target price forecast
Forecast dateSep 4, 2026
Forecast met7.2%
Stock price$28.49
Avg. target$23.6
High target$26
Low target$19
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.